Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: Per aspirin ad astra

European Heart Journal

Volumn 34, Issue 44, 2013, Pages 3400-3402

  Cavarretta, Elena ^a   Chiariello, Giovanni Alfonso ^b   Condorelli, Gianluigi ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Milan Unit   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPRENOLOL; BIOLOGICAL MARKER; MICRORNA 126; PLACEBO; PROSTAGLANDIN G2; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; VON WILLEBRAND FACTOR;

BINDING SITE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PLATELET REACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

ASPIRIN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MICRORNAS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS;

EID: 84883233142     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht032     Document Type: Review

References (14)

1. Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009;6:419-429.
2. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating micro-RNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012;93: 555-562.
3. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012;60:290-299.
4. Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O. Serum levels of micro-RNAs in patients with heart failure. Eur J Heart Fail 2012;14:147-154.
5. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107: 677-684.
6. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A,Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817.
7. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51: 872-875.
8. Contu R, Latronico MV, Condorelli G. Circulating microRNAs as potential biomarkers of coronary artery disease: A promise to be fulfilled? Circ Res 2010; 107:573-574.
9. Mocharla P, Briand S, Giannotti G, Dorries C, Jakob P, Paneni F, Luscher T, Landmesser U. AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013;121:226-236.
10. de Boer HC, van Solingen C, Prins J, Duijs JMGJ, Huisman MV, Rabelink TJ, van Zonneveld AJ. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 2013;34: 3451-3457.
11. Luo GP, Ni B, Yang X, Wu YZ. von Willebrand factor: more than a regulator of hemostasis and thrombosis. Acta Haematol 2012;128:158-169.
12. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King AS, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley S, Sivaprasad S, Markus HS, Mitchell JA, Warner T, Kiechl S, Mayr M. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res; doi:10.1161/circresaha.111.300539. Published online ahead of print 2 January 2013.
13. Zampetaki A, Mayr M. Analytical challenges and technical limitations in assessing circulating miRNAs. Thromb Haemost 2012;108:592-598.
14. Condorelli G, Latronico MV, Dorn GW 2nd. microRNAs in heart disease: putative novel therapeutic targets? Eur Heart J 2010;31:649-658.